Antimicrobial growth promoter ban and resistance to macrolides and vancomycin in enterococci from pigs

J Clin Microbiol. 2001 Nov;39(11):4193-5. doi: 10.1128/JCM.39.11.4193-4195.2001.

Abstract

Ninety-six enterococcus isolates from fecal samples of pigs receiving tylosin as an antimicrobial growth promoter and 59 isolates obtained in the same farms 5 to 6 months after the ban of antimicrobial growth promoters in Switzerland were tested for susceptibility to nine antimicrobial agents. A clear decrease in resistance to macrolides, lincosamides, and tetracycline was visible after the ban. Vancomycin-resistant Enterococcus faecium belonged to the same clonal lineage as vancomycin-resistant isolates previously isolated from Danish pigs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Bacterial*
  • Enterococcus / drug effects*
  • Feces / microbiology
  • Glycopeptides
  • Growth Substances / administration & dosage
  • Legislation, Drug*
  • Legislation, Veterinary*
  • Microbial Sensitivity Tests
  • Swine / growth & development
  • Swine / microbiology
  • Switzerland
  • Tylosin / administration & dosage
  • Vancomycin Resistance*

Substances

  • Anti-Bacterial Agents
  • Glycopeptides
  • Growth Substances
  • avoparcin
  • Tylosin